Mantle cell lymphoma tends to grow quickly. When doctors find this type of cancer, it’s usually widespread throughout your body already. This can make treatment more difficult. But doctors have ...

This type affects 1 in 20 people with lymphoma and is more common in older adults and men. It forms in your spleen, lymph nodes, or bone marrow. Mantle cell lymphoma grows slowly but can be hard ...

There are currently dozens of clinical trials examining new ways to treat mantle cell lymphoma (MCL). People can learn about trial recruitment at ClinicalTrials.gov. Research into mantle cell ...

In a real-world study, researchers found this data by comparing treatment patterns, healthcare resource utilization, and ...

In a case report published in the World Journal of Oncology, an elderly female patient was diagnosed with mast cell leukemia (MCL), with imaging showing extensive osteoblastic metastatic lesions. MCL ...

Wojciech Jurczak, MD, PhD, ​​discusses the future of B-cell lymphoma therapy, with a focus on Bruton's tyrosine kinase ...

Gilead Sciences’ Kite Pharma unit is closing on approval of its second European approval for a CAR-T for cancer, after the CHMP backed its KTE-X19 therapy for mantle cell lymphoma.

The ELM-2 trial included 5 independent disease-specific groups (DLBCL, FL, mantle cell lymphoma, marginal zone lymphoma and other subtypes of B-cell non-Hodgkin lymphoma). Among the 128 R/R FL ...